biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and pain-relief properties of Mesenchymal Stem Cells. In contrast to traditional chemical-based pharmaceuticals, the bio-based variants being developed by Bioceltix are effective in the long-term. That’s because they utilise the natural processes taking place in the human body – which also means – no side effects. There’s more. These innovative meds can also help sick tissue rebuild, because of strong healing properties they have.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
Articleproseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this ...
Read fullAll of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory ...
Read fullThe gala that concluded the 8th edition of this ranking took place on June 27th at Warsaw’s Multikino Złote Tarasy. This time the event was ...
Read full
